Hi OWL - also looking forward to PK's report of Cannatech.
No, I'm not an accountant - have been in the finance area for over 30 years with some tertiary accountancy training.
R&D can get very complicated - essentially a Tax off-set with lots of rules. Not only the type of science involved but getting to where a company is registered etc etc. Your question is a very good one though - RMIT and Notre Dame may well qualify for R7D off-sets. It could be that MXC is an overseas registered business and that may affect R&D qualifications that does not disqualify them. Be a very good question to pose to MXC itself.
Ann: September Quarterly Activity and Cashflow Report, page-53
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable